Health TrialsbyHealthPanel

Effect of Ultrasound Cavitation on Insulin Resistance in Patients with Central Obesity in Female

ConditionCentral Obesity
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age25-40
SponsorCairo University

About this trial

The purpose of this study was to investigate the effect of ultrasound cavitation on insulin resistance, HbA1c and skin fold in patients with abdominal central obesity.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Female subjects with central obesity.

Female participants aged between 25 to 40 years.

Body Mass Index (BMI) ranged from 30 to 35 kg/m2 as high BMI indicates more obesity and central obesity.

Waist circumference greater than 88 cm, indicative of abdominal obesity.

Disqualifiers

• Subjects diagnosed with DM (HbA1c more than 6.5%).

History of metabolic disorders such as type 1 diabetes or thyroid disorders.

Subjects with BMI less than 30 kg/m2.

Subjects diagnosed with heart disease, liver as well as kidney diseases.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Ultrasound cavitation

    Device

    Ultrasound Fat Cavitation (USFC) is the method in handling obesity, especially in destroying fat and shaping a particular part of the body. As one of the non-surgical correction methods, USFC is preferred at decreasing the risk of complications due to obesity.

  • Exercise

    Other intervention

    The female will stand on the cushioned tread and grasp by her both hands the two arms of the treadmill. Treadmill will adjust to apply moderate intensity training. It was used for 30 minutes divided into five-minutes warming up, twenty-minutes active exercise and five-minutes cooling down and it was used twice a week for twelve weeks.

Treatment groups

52 Participants
are divided into 2 treatment groups
Group A: Group AExperimental treatment 1 intervention
Group B: Group BActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

HOMA ir

This study will evaluate changes in HOMA-IR from baseline to assess improvements in insulin sensitivity because of the ultrasound cavitation intervention.

Time frame
"From enrollment to the end of treatment at 8 weeks"

Secondary outcomes

1

Skin fold by caliper

The skinfold measurements will be taken using a Lange Skinfold Caliper, which provides accurate and reliable readings

Time frame
"From enrollment to the end of treatment at 8 weeks"
2

Waist circumference (WC) by tape measurement

Waist circumference (WC) is an essential anthropometric measure used to evaluate abdominal obesity. It serves as an indicator of visceral fat, which is associated with a higher risk of metabolic disorders, including insulin resistance, type 2 diabetes, and cardiovascular diseases. By measuring waist circumference.

Time frame
"From enrollment to the end of treatment at 8 weeks"

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Cairo University

Lead sponsor

Source ClinicalTrials.gov
Apply now